Provided by Tiger Trade Technology Pte. Ltd.

Prestige

46.68
-0.9400-1.97%
Volume:767.13K
Turnover:36.06M
Market Cap:2.21B
PE:13.06
High:48.25
Open:47.22
Low:46.38
Close:47.62
52wk High:71.07
52wk Low:42.62
Shares:47.32M
Float Shares:46.69M
Volume Ratio:1.54
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.58
EPS(LYR):3.91
ROE:9.12%
ROA:4.58%
PB:1.15
PE(LYR):11.94

Loading ...

Prestige Consumer Healthcare to join fireside chat at Oppenheimer Consumer Growth and E-Commerce Conference

Reuters
·
Jun 05

Is Prestige Consumer Healthcare’s (PBH) Dramamine Expansion Quietly Reshaping Its OTC Brand Strength Narrative?

Simply Wall St.
·
Jun 02

TTK Prestige Posts Q4 FY26 Earnings Call Transcript, Reaffirms Disclosure Norms

TIPRANKS
·
May 28

Prestige Estates Projects Limited (PRESTIGE) Gets a Buy from Jefferies

TIPRANKS
·
May 25

Jefferies Adjusts Prestige Estates Projects' Price Target to INR1,675 From INR1,635, Keeps at Buy

MT Newswires Live
·
May 25

Do Prestige’s Higher Margins and New Dramamine Formats Reveal a Sharper Brand Strategy for PBH?

Simply Wall St.
·
May 25

Prestige Estates Projects' Consolidated Profit Jumps in Fiscal Q4

MT Newswires Live
·
May 22

TTK Prestige Swings to Profit in Fiscal Q4

MT Newswires Live
·
May 22

TTK Prestige Shares Q4 and FY26 Analyst Data via Investor Presentation

TIPRANKS
·
May 22

Prestige International Sets Post-AGM Board Line-Up as One Director Retires

TIPRANKS
·
May 21

Prestige Consumer Healthcare Balances Volatility and Growth

TIPRANKS
·
May 20

Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 16

U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

Reuters
·
May 15

Prestige Biologics Secures KRW2.4 Billion Contract Manufacturing Agreement for APIs

MT Newswires Live
·
May 15

Prestige Consumer Healthcare (PBH) Margin Slippage Tests Bullish Valuation Narratives In FY 2026

Simply Wall St.
·
May 15

Prestige Consumer falls -14.0%

TIPRANKS
·
May 15

Prestige Consumer Shares Slide on Weak Outlook, 4Q Underperformance

Dow Jones
·
May 15

Prestige Consumer Hlthcr Cut to Perform From Outperform by Oppenheimer

Dow Jones
·
May 15

Prestige Consumer Healthcare Down Over 13%, On Track for Largest Percent Decrease Since May 2012 -- Data Talk

Dow Jones
·
May 14

Prestige Consumer Faces Execution Pressure After Weak Q4, Softer 2026 Outlook, Oppenheimer Says

MT Newswires Live
·
May 14